Pelthos Therapeutics Inc. (PTHS) Stock

Pelthos Therapeutics Inc. (PTHS) is a Healthcare stock trading at $27.50 (as of 2026-06-18), with a market capitalization of $92.00M and a trailing P/E of -1.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

Valuation — source: SEC EDGAR (first-party)
Price$27.50
Market Cap$92.00M
P/E Ratio-1.0
EV / EBITDA-1.4
Price / Book2.62
Price / Sales3.32
DCF Value (model)$-109.75
DCF Upside vs Price-499.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$16.80M
Net Margin-257.9%
Return on Equity-147.0%
Current Ratio2.79
Financial Health — source: SEC EDGAR
Altman Z-Score-0.53 (distress)
Valuation vs Sector & Industry
Stock P/E-1.0
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-104.9%
vs Industry-106.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderMurchinson Ltd. ($6.23M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOScott Plesha
Employees4
CountryUS
IPO Date2025-07-02

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • MacroGenics, Inc. (MGNX)
  • Champions Oncology, Inc. (CSBR)
  • Precision BioSciences, Inc. (DTIL)
  • Sutro Biopharma, Inc. (STRO)
  • Cypherpunk Technologies Inc. (CYPH)
  • Oncolytics Biotech Inc. (ONCY)
  • Cardiol Therapeutics Inc. (CRDL)
  • Equillium, Inc. (EQ)
PTHS earnings history · PTHS institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.